IVI to ready clinical trial sites for COVID-19 vaccine efficacy trials in 4 countries

(International Vaccine Institute) The International Vaccine Institute (IVI) announced today that the Bill & Melinda Gates Foundation awarded close to 1.5 million USD to IVI to support clinical trial site preparedness in four African and Asian countries to potentially support future COVID-19 Phase III efficacy vaccine trials.